Many beneficial proteins have limited natural availability, which often restricts their supply and thereby reduces their potential for therapeutic or industrial usage. The advent of recombinant DNA (rDNA) technology enables the utilization of different microbes as surrogate hosts to facilitate the production of these proteins. This microbial technology continues to evolve and integrate with modern innovations to develop more effective approaches for increasing the production of recombinant biopharmaceuticals. These strategies encompass fermentation technology, metabolic engineering, the deployment of strong promoters, novel vector elements such as inducers and enhancers, protein tags, secretion signals, synthetic biology, high-throughput devices for cloning, and process screening. This appraisal commences with a general overview regarding the manufacture of recombinant proteins by microbes and the production of biopharmaceuticals, their trends towards the development of biopharmaceuticals, and then discusses the approaches adopted for accomplishing this. The design of the upstream process, which also involves host selection, vector design, and promoter design, is a crucial component of production strategies. On the other hand, the downstream process focuses on extraction and purification techniques. Additionally, the review covers the most modern tools and resources, methods for overcoming low expression, the cost of producing biopharmaceuticals in microbes, and readily available recombinant protein products.
Ectoine is an osmoregulatory compound synthesized by halophiles which has attracted attention in the biotechnology, pharmaceuticals, and cosmetics industries due to its stabilizing and protective properties. Conventional methods for ectoine recovery are complex, costly, and often result in low yields. Therefore, there is a growing interest in exploring simple and cost-effective strategies for ectoine recovery. The aqueous biphasic system (ABS) has been employed for the recovery and purification of numerous biocompounds, but the study of low-molecular weight compounds partitioning in ABS remains limited. This study aimed to investigate the feasibility of alcohol–salt ABS for ectoine recovery from Halomonas salina DSM5928T cells. The influences of types and compositions of phase-forming components, crude load concentration, pH, and adjuvants on ectoine recovery were evaluated. Results revealed that ectoine favoured partitioning into the salt-rich bottom phase of alcohol–salt ABS owing to its inherent hydrophilic characteristic. ABS consisting of 16% (w/w) 1-propanol, 20% (w/w) sulphate at pH 6.0, 30% (w/w) crude load, and 1% (w/w) sodium chloride resulted in a partition coefficient ( of 9.61 ± 0.05 and a yield ( of 97.50% ± 0.21. A purity ( of 86.73% was achieved with the 1-propanol-sulphate ABS. Alcohol–salt ABS proved to be an effective approach for ectoine recovery, meeting the raising market demand for industrial applications.